Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Meier

Showing results (281-290 of 305) with videos related to

Pageof 31
Sort By:
European Journal of Preventive Cardiology|March 29, 2019
ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicineInes Frederix, Enrico G Caiani, Paul Dendale, et al.
Circulation. Cardiovascular Quality and Outcomes|November 6, 2014
Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in LondonM Bilal Iqbal, Charles Ilsley, Tito Kabir, et al.
Cell Reports|April 12, 2018
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic PotentialRebecca Feltham, Kunzah Jamal, Tencho Tenev, et al.
Circulation. Cardiovascular Interventions|June 4, 2015
Time-trend analyses of bleeding and mortality after primary percutaneous coronary intervention during out of working hours versus in-working hours: an observational study of 11 466 patientsM Bilal Iqbal, Ramzi Khamis, Charles Ilsley, et al.
The American Journal of Cardiology|March 24, 2015
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary interventionFabrizio D'Ascenzo, Salma Taha, Claudio Moretti, et al.
Development (Cambridge, England)|June 20, 2022
ERG activity is regulated by endothelial FAK coupling with TRIM25/USP9x in vascular patterningGabriela D'Amico, Isabelle Fernandez, Jesús Gómez-Escudero, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2018
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity AnalysisMohamed Salla, Rodrigo Aguayo-Ortiz, Gaddafi I Danmaliki, et al.
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Molecular Cell|January 2, 2019
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and InflammationGianmaria Liccardi, Laura Ramos Garcia, Tencho Tenev, et al.
Clinical Cardiology|May 21, 2015
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study designHeerajnarain Bulluck, Georg M Fröhlich, Shah Mohdnazri, et al.
Pageof 31

Showing results (281-290 of 305) with videos related to

Sort By:
Pageof 31
European Journal of Preventive Cardiology|March 29, 2019
ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicineInes Frederix, Enrico G Caiani, Paul Dendale, et al.
Circulation. Cardiovascular Quality and Outcomes|November 6, 2014
Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in LondonM Bilal Iqbal, Charles Ilsley, Tito Kabir, et al.
Cell Reports|April 12, 2018
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic PotentialRebecca Feltham, Kunzah Jamal, Tencho Tenev, et al.
Circulation. Cardiovascular Interventions|June 4, 2015
Time-trend analyses of bleeding and mortality after primary percutaneous coronary intervention during out of working hours versus in-working hours: an observational study of 11 466 patientsM Bilal Iqbal, Ramzi Khamis, Charles Ilsley, et al.
The American Journal of Cardiology|March 24, 2015
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary interventionFabrizio D'Ascenzo, Salma Taha, Claudio Moretti, et al.
Development (Cambridge, England)|June 20, 2022
ERG activity is regulated by endothelial FAK coupling with TRIM25/USP9x in vascular patterningGabriela D'Amico, Isabelle Fernandez, Jesús Gómez-Escudero, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2018
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity AnalysisMohamed Salla, Rodrigo Aguayo-Ortiz, Gaddafi I Danmaliki, et al.
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Molecular Cell|January 2, 2019
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and InflammationGianmaria Liccardi, Laura Ramos Garcia, Tencho Tenev, et al.
Clinical Cardiology|May 21, 2015
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study designHeerajnarain Bulluck, Georg M Fröhlich, Shah Mohdnazri, et al.
Pageof 31